SELECTBIO – Clinical Translation of Stem Cells 2014

Agenda Topics

Jeff Fan, Exhibition Manager Jeff@selectbio.us +1 510-857-4865

Mark Berman, Past President, American Academy of Cosmetic Surgery; Medical Director, California Stem Cell Treatment Center Gregorio Chazenbalk, Research Associate, Dept of Obstetrics and Gynecology, University of California-Los Angeles Aaron Cipriano, Student, University of California-Riverside Kristin Comella, Chief Scientific Officer, Bioheart, Inc. Ann Cooper, Research Veterinarian, University of California-Irvine Devon Duron Ehnes, Graduate Student, University of California-Riverside Richard Enmon, US and EU Registered Patent Attorney, Vossius and Partner John Feller, Medical Director, Desert Medical Imaging Fred Fox, Ethicist, BioMedical Research Institute -- BioMed IRB Henry Klassen, Associate Professor, University of California Irvine Elliot Lander, Medical Director, California Stem Cell Treatment Center Jiayu Liao, Associate Professor, Bioengineering and Stem Cells, University of California, Riverside Dennis Lox, Physician, Florida Spine and Sports Medicine Center Maricela Maldonado, Bioengineering, University of California-Riverside Daniel Nampe, Bioengineering, University of California-Riverside Vincent On, Electrical Engineering, University of California-Riverside Michael Pazzani, Vice Chancellor for Research and Economic Development, University of California-Riverside Ken Pettine, Fellowship Trained Spine Surgeon, Premier Stem Cell Institute Sicco Popma, Scientific Director, Johnson & Johnson Joseph Purita, Medical Director of Stem Cell Centers of America, Institute Of Regenerative and Molecular Orthopedics Ron Shane, Medical and Research Director, Millennia Concepts Biotech, LLC/American Academy of Anti-aging Medicine John Sterling, Editor-in-Chief, Genetic Engineering & Biotechnology News Shigeki Sugii, Group Leader, Singapore Bioimaging Consortium Prue Talbot, Director, Stem Cell Center, UC Riverside Atena Zahedi, Researcher, University of California-Riverside

This Conference and Associated Clinical Practicum is Ideally Suited for the Following Audiences:

This Conference will include a Panel Discussion led by the Editor-in-Chief of GEN:

John Sterling, Editor-in-Chief, Genetic Engineering & Biotechnology News (GEN) will lead a panel focusing on stem cell publications and major industry trends in the broader stem cell field.

Regulatory Trends and Ethics Issues:

Mr. Fred Fox, Chairman, BioMed IRB will focus on regulatory trends and ethics issues to be addressed as stem cell research translates towards the clinic.

Clinical Practicum on Day 1 Evening After Conclusion of Main Conference Presentations:

Offers Delegates Hands-on View of Adipose-derived Stem Cell Harvest, Generation of the SVF, and Demonstration of Tools and Technologies Utilized by Clinicians [Will be Hosted by Local Surgery Center and Performed by Licensed Clinicians in Full Compliance with Relevant Regulations].

Kosher Food Available for Speakers and Delegates:

Since this conference is held on the last two days of Passover, we will be offering Kosher Food to respect the dietary requirements of our speakers and delegates.

See the article here:
SELECTBIO - Clinical Translation of Stem Cells 2014